Beam Therapeutics Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| FMR LLC | — | Sale | 459 | $26.68 | $12,246 | 14 | Oct 27, 2025 |
| FMR LLC | — | Gift | 1,232,434 | — | — | 841,231 | Oct 6, 2025 |
| Cavanagh Bethany J | SVP, Finance and Treasurer | Sale | 467 | $24.53 | $11,456 | 44,045 | Oct 1, 2025 |
| Bellon Christine | Chief Legal Officer | Sale | 373 | $24.53 | $9,150 | 116,921 | Oct 1, 2025 |
| Evans John M. | CEO | Option Exercise | 25,000 | $0.67 | $16,750 | 1,011,667 | Oct 1, 2025 |
| FMR LLC | — | Sale | 48,374 | $20.50 | $991,667 | 2,073,665 | Jul 30, 2025 |
| Simon Amy | Chief Medical Officer | Sale | 876 | $20.12 | $17,625 | 64,864 | Jul 1, 2025 |
| Simon Amy | Chief Medical Officer | Sale | 9,566 | $18.35 | $175,536 | 86,739 | Apr 2, 2025 |
| Bellon Christine | Chief Legal Officer | Sale | 5,674 | $18.35 | $104,118 | 117,294 | Apr 1, 2025 |
| Evans John M. | CEO | Sale | 30,663 | $18.35 | $562,666 | 986,249 | Apr 1, 2025 |
| Ciaramella Giuseppe | President | Sale | 7,434 | $18.35 | $136,414 | 190,216 | Apr 1, 2025 |
| Cavanagh Bethany J | SVP, Finance and Treasurer | Sale | 3,015 | $18.35 | $55,325 | 44,512 | Apr 1, 2025 |
| Bellon Christine | Chief Legal Officer | Award / Grant | 20,000 | — | — | 122,968 | Mar 31, 2025 |
| Simon Amy | Chief Medical Officer | Award / Grant | 27,500 | — | — | 96,305 | Mar 31, 2025 |
| Ciaramella Giuseppe | President | Award / Grant | 35,000 | — | — | 197,650 | Mar 31, 2025 |
| Cavanagh Bethany J | SVP, Finance and Treasurer | Award / Grant | 10,000 | — | — | 47,527 | Mar 31, 2025 |
| Evans John M. | CEO | Award / Grant | 77,500 | — | — | 1,016,159 | Mar 31, 2025 |
| Cavanagh Bethany J | SVP, Finance and Treasurer | Sale | 6,287 | $35.00 | $220,045 | 37,527 | Feb 18, 2025 |
| Bellon Christine | Chief Legal Officer | Option Exercise | 9,492 | $7.22 | $68,532 | 112,460 | Feb 14, 2025 |
| Evans John M. | CEO | Option Exercise | 30,000 | $0.67 | $20,100 | 968,659 | Jan 30, 2025 |
| Evans John M. | CEO | Sale | 29,800 | $26.75 | $797,150 | 908,859 | Jan 30, 2025 |
| Bellon Christine | Chief Legal Officer | Sale | 1,241 | $24.68 | $30,628 | 102,968 | Jan 2, 2025 |
| Cavanagh Bethany J | SVP, Finance and Treasurer | Sale | 1,117 | $24.68 | $27,568 | 43,814 | Jan 2, 2025 |
| Emany Sravan Kumar | Chief Financial Officer | Award / Grant | 80,000 | — | — | 80,000 | Dec 31, 2024 |
| Ciaramella Giuseppe | President | Option Exercise | 53,500 | $0.67 | $35,845 | 162,650 | Dec 17, 2024 |
| Ciaramella Giuseppe | President | Sale | 51,110 | $26.36 | $1,347,260 | 109,150 | Nov 6, 2024 |
| Ciaramella Giuseppe | President | Option Exercise | 12,979 | $4.22 | $54,771 | 209,913 | Oct 14, 2024 |
| Bellon Christine | Chief Legal Officer | Sale | 385 | $23.48 | $9,040 | 104,209 | Oct 1, 2024 |
| Cavanagh Bethany J | SVP, Finance and Treasurer | Sale | 289 | $23.48 | $6,786 | 44,931 | Sep 30, 2024 |
| Evans John M. | CEO | Sale | 60,000 | $24.60 | $1,476,000 | 938,659 | Sep 30, 2024 |
| Simon Amy | Chief Medical Officer | Sale | 748 | $22.95 | $17,167 | 68,805 | Jul 1, 2024 |
| Evans John M. | CEO | Sale | 60,000 | $24.50 | $1,470,000 | 998,343 | Jun 27, 2024 |
| Burrell Terry-Ann | Chief Financial Officer | Award / Grant | 12,500 | — | — | 82,637 | Apr 26, 2024 |
| Simon Amy | Chief Medical Officer | Sale | 7,157 | $32.13 | $229,954 | 86,590 | Apr 2, 2024 |
| Bellon Christine | Chief Legal Officer | Sale | 3,401 | $32.12 | $109,240 | 104,594 | Apr 1, 2024 |
| Burrell Terry-Ann | Chief Financial Officer | Sale | 5,446 | $32.12 | $174,926 | 70,137 | Apr 1, 2024 |
| Evans John M. | CEO | Sale | 18,102 | $32.13 | $581,617 | 1,058,343 | Apr 1, 2024 |
| Ciaramella Giuseppe | President | Sale | 4,534 | $32.12 | $145,632 | 169,616 | Apr 1, 2024 |
| Burrell Terry-Ann | Chief Financial Officer | Award / Grant | 27,500 | — | — | 75,583 | Mar 31, 2024 |
| Simon Amy | Chief Medical Officer | Award / Grant | 27,500 | — | — | 93,747 | Mar 31, 2024 |
| Bellon Christine | Chief Legal Officer | Award / Grant | 27,500 | — | — | 107,995 | Mar 31, 2024 |
| Ciaramella Giuseppe | President | Award / Grant | 35,000 | — | — | 174,150 | Mar 31, 2024 |
| Evans John M. | CEO | Award / Grant | 77,500 | — | — | 1,076,445 | Mar 28, 2024 |
| FMR LLC | — | Sale | 1,155 | $30.93 | $35,724 | 2,771,913 | Feb 14, 2024 |
| Evans John M. | CEO | Sale | 60,000 | $25.33 | $1,519,800 | 1,058,262 | Jan 31, 2024 |
| Bellon Christine | Chief Legal Officer | Sale | 1,907 | $26.42 | $50,383 | 80,495 | Jan 3, 2024 |
| FMR LLC | — | Other | 29,549 | — | — | 2,773,478 | Dec 22, 2023 |
| Bellon Christine | Chief Legal Officer | Option Exercise | 4,182 | $7.22 | $30,194 | 86,584 | Nov 20, 2023 |
| Simon Amy | Chief Medical Officer | Sale | 3,448 | $18.70 | $64,478 | 65,469 | Oct 30, 2023 |
| Ciaramella Giuseppe | President and CSO | Option Exercise | 90,900 | $0.67 | $60,903 | 139,150 | Oct 20, 2023 |